"cns drug" - Google News

Impact of CNS medication burden and drug interactions on delirium in patients with advanced cancer: a multicenter prospective observational study - Nature

Tue, 11 Nov 2025 08:00:00 GMT

Impact of CNS medication burden and drug interactions on delirium in patients with advanced cancer: a multicenter prospective observational study Nature

Lunai Bioworks to acquire CNS drug delivery platform and Alzheimer’s assets for $20M - MSN

Wed, 29 Apr 2026 18:38:25 GMT

Lunai Bioworks to acquire CNS drug delivery platform and Alzheimer’s assets for $20M MSN

ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15' - Morningstar

Wed, 22 Apr 2026 06:56:24 GMT

ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15' Morningstar

Bee Stinger-Like Wearable Electrospun Web Microneedles for Sustained CNS Drug Delivery - Wiley

Thu, 31 Jul 2025 07:00:00 GMT

Bee Stinger-Like Wearable Electrospun Web Microneedles for Sustained CNS Drug Delivery Wiley

Insilico Medicine and Tenacia Biotechnology Expand AI-Driven CNS Collaboration with Deal Value Up to US$94.75 Million - Insilico Medicine

Wed, 25 Mar 2026 07:00:00 GMT

Insilico Medicine and Tenacia Biotechnology Expand AI-Driven CNS Collaboration with Deal Value Up to US$94.75 Million Insilico Medicine

AtaiBeckley (ATAI) Reports Phase 2a Data in CNS Drugs - Yahoo Finance

Sun, 12 Apr 2026 07:00:00 GMT

AtaiBeckley (ATAI) Reports Phase 2a Data in CNS Drugs Yahoo Finance

News Updates - Chinese researchers advance central nerve system drug delivery for stroke therapy - nsfc.gov.cn

Mon, 13 Apr 2026 13:51:29 GMT

News Updates - Chinese researchers advance central nerve system drug delivery for stroke therapy nsfc.gov.cn

Innovative direct delivery strategies to unlock oligonucleotide therapeutics for CNS disorders - pharmaphorum

Fri, 24 Apr 2026 10:38:39 GMT

Innovative direct delivery strategies to unlock oligonucleotide therapeutics for CNS disorders pharmaphorum

The New Gold Rush in Brain Science - BioSpace

Thu, 22 Jan 2026 08:00:00 GMT

The New Gold Rush in Brain Science BioSpace

Tortugas Neuroscience Launches With $106 Million to Advance Mid-Stage CNS Drug Pipeline - citybiz

Tue, 21 Apr 2026 13:48:35 GMT

Tortugas Neuroscience Launches With $106 Million to Advance Mid-Stage CNS Drug Pipeline citybiz

Bexorg wins $23M to end CNS drug trial failures using AI — and human brains - FirstWord Pharma

Wed, 15 Oct 2025 07:00:00 GMT

Bexorg wins $23M to end CNS drug trial failures using AI — and human brains FirstWord Pharma

One in four older Americans with dementia prescribed risky brain-altering drugs despite safety warnings - UCLA Health

Mon, 12 Jan 2026 08:00:00 GMT

One in four older Americans with dementia prescribed risky brain-altering drugs despite safety warnings UCLA Health

Event guide: The 7th CNS Drug Delivery Summit - News-Medical

Wed, 26 Nov 2025 16:52:06 GMT

Event guide: The 7th CNS Drug Delivery Summit News-Medical

Neurotherapeutics across blood–brain barrier: screening of BBB-permeable and CNS-active molecules for neurodegenerative disease - Frontiers

Thu, 25 Sep 2025 07:00:00 GMT

Neurotherapeutics across blood–brain barrier: screening of BBB-permeable and CNS-active molecules for neurodegenerative disease Frontiers

CNS-active medication use and adverse health outcomes among Thai older adults: a population-based retrospective study - Nature

Mon, 26 Jan 2026 08:00:00 GMT

CNS-active medication use and adverse health outcomes among Thai older adults: a population-based retrospective study Nature

CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions - PR Newswire

Mon, 09 Mar 2026 07:00:00 GMT

CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions PR Newswire

Editorial: New approaches to overcome the blood-brain barrier for the treatment of CNS disorders - Frontiers

Fri, 24 Oct 2025 08:53:50 GMT

Editorial: New approaches to overcome the blood-brain barrier for the treatment of CNS disorders Frontiers

Immune gateways bypass blood–brain barrier for drug delivery in stroke - Nature

Wed, 11 Feb 2026 08:00:00 GMT

Immune gateways bypass blood–brain barrier for drug delivery in stroke Nature

Hijacking skull immune cells to bypass the blood-brain barrier for brain drug delivery - EurekAlert!

Tue, 20 Jan 2026 08:00:00 GMT

Hijacking skull immune cells to bypass the blood-brain barrier for brain drug delivery EurekAlert!

How blood–brain barrier technology is unleashing CNS therapies - Nature

Mon, 01 Sep 2025 19:24:25 GMT

How blood–brain barrier technology is unleashing CNS therapies Nature

Luye Pharma Starts U.S. PK Bridging Trial for Novel CNS Drug LY03015 - TipRanks

Mon, 20 Apr 2026 07:00:00 GMT

Luye Pharma Starts U.S. PK Bridging Trial for Novel CNS Drug LY03015 TipRanks

OVID: 2025 saw higher revenue, reduced losses, and strong cash to support advancing CNS drug programs - TradingView

Wed, 18 Mar 2026 07:00:00 GMT

OVID: 2025 saw higher revenue, reduced losses, and strong cash to support advancing CNS drug programs TradingView

Lunai Bioworks Acquires $20M in BBB Delivery Tech, CNS Alzheimer’s Assets from Clemann Group - Contract Pharma

Thu, 26 Mar 2026 07:00:00 GMT

Lunai Bioworks Acquires $20M in BBB Delivery Tech, CNS Alzheimer’s Assets from Clemann Group Contract Pharma

AVXL: Net loss narrowed and cash reserves grew, supporting continued CNS drug development - TradingView

Mon, 09 Feb 2026 08:00:00 GMT

AVXL: Net loss narrowed and cash reserves grew, supporting continued CNS drug development TradingView

Praxis Precision Medicines: Latest Study Wins Sets Up 2 CNS Drug Approvals In 2026 (PRAX) - Seeking Alpha

Fri, 05 Dec 2025 08:00:00 GMT

Praxis Precision Medicines: Latest Study Wins Sets Up 2 CNS Drug Approvals In 2026 (PRAX) Seeking Alpha

Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications - PR Newswire

Thu, 26 Mar 2026 07:00:00 GMT

Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications PR Newswire

Frontiers and challenges in brain drug delivery: Emerging nanotechnology approaches to overcome the blood-brain barrier for neurodegenerative disease treatment - ScienceDirect.com

Mon, 17 Nov 2025 03:43:34 GMT

Frontiers and challenges in brain drug delivery: Emerging nanotechnology approaches to overcome the blood-brain barrier for neurodegenerative disease treatment ScienceDirect.com

This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain - The Motley Fool

Wed, 18 Mar 2026 07:00:00 GMT

This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain The Motley Fool

EQT Foundation opens applications for science grants to overcome the blood-brain barrier and transform CNS drug delivery - Cision News

Tue, 10 Mar 2026 07:00:00 GMT

EQT Foundation opens applications for science grants to overcome the blood-brain barrier and transform CNS drug delivery Cision News

Biogen acquires Alcyone to boost CNS drug delivery - Medical Device Network

Mon, 17 Nov 2025 08:00:00 GMT

Biogen acquires Alcyone to boost CNS drug delivery Medical Device Network

Cycle buying Applied Therapeutics to develop CNS drugs - BioWorld News

Fri, 12 Dec 2025 08:00:00 GMT

Cycle buying Applied Therapeutics to develop CNS drugs BioWorld News

Repurposing of CNS accumulating drugs Gemfibrozil and Doxylamine for enhanced sensitization of glioblastoma cells through modulation of autophagy - Nature

Tue, 01 Jul 2025 07:00:00 GMT

Repurposing of CNS accumulating drugs Gemfibrozil and Doxylamine for enhanced sensitization of glioblastoma cells through modulation of autophagy Nature

Biopharma Bites: Insilico snags an NLRP3, FDA's manufacturing pilot, plus more from Lisata and Cylembio - FirstWord Pharma

Wed, 21 Jan 2026 08:00:00 GMT

Biopharma Bites: Insilico snags an NLRP3, FDA's manufacturing pilot, plus more from Lisata and Cylembio FirstWord Pharma

Potentially Inappropriate CNS-Active Medications Continue to Be Prescribed to Older Adults in the United States - U.S. Medicine

Thu, 12 Feb 2026 08:00:00 GMT

Potentially Inappropriate CNS-Active Medications Continue to Be Prescribed to Older Adults in the United States U.S. Medicine

Peripheral nerve barrier and its implications for drug delivery - ScienceDirect.com

Sat, 26 Jul 2025 20:13:17 GMT

Peripheral nerve barrier and its implications for drug delivery ScienceDirect.com

Biohaven, Bexorg Partner to Accelerate CNS Drug Discovery Using Novel Whole-Brain Platform - Yahoo Finance

Tue, 15 Jul 2025 07:00:00 GMT

Biohaven, Bexorg Partner to Accelerate CNS Drug Discovery Using Novel Whole-Brain Platform Yahoo Finance

LG CNS joins government AI drug development program - The Korea Herald

Wed, 21 Jan 2026 08:00:00 GMT

LG CNS joins government AI drug development program The Korea Herald

CNS drug market to hit $235.9b by 2033 as neurological diseases surge - Healthcare Asia Magazine

Thu, 15 Jan 2026 08:00:00 GMT

CNS drug market to hit $235.9b by 2033 as neurological diseases surge Healthcare Asia Magazine

Transforming CNS drug discovery using ‘reactivated’ human brains - Longevity.Technology

Thu, 16 Oct 2025 07:00:00 GMT

Transforming CNS drug discovery using ‘reactivated’ human brains Longevity.Technology

Co-culturing endothelial cells and pericytes to assess drug BBB penetration - News-Medical

Fri, 09 Jan 2026 08:00:00 GMT

Co-culturing endothelial cells and pericytes to assess drug BBB penetration News-Medical

MapLight scores $372.5m to chart new territory in CNS drug development - BioXconomy

Thu, 31 Jul 2025 07:00:00 GMT

MapLight scores $372.5m to chart new territory in CNS drug development BioXconomy

New Tools to Advance CNS Drug Delivery - Aptar

Mon, 10 Nov 2025 11:55:23 GMT

New Tools to Advance CNS Drug Delivery Aptar

Prediction of blood-brain barrier penetration of PET CNS drugs enabled by explainable machine learning - Journal of Nuclear Medicine

Sun, 01 Jun 2025 07:00:00 GMT

Prediction of blood-brain barrier penetration of PET CNS drugs enabled by explainable machine learning Journal of Nuclear Medicine

South Carolina lab pleads guilty in $6.8M kickback case; 1 in 4 dementia patients prescribed risky CNS drugs; FDA eases manufacturing rules for cell and gene therapies – Morning Medical Update - Medical Economics

Tue, 13 Jan 2026 08:00:00 GMT

South Carolina lab pleads guilty in $6.8M kickback case; 1 in 4 dementia patients prescribed risky CNS drugs; FDA eases manufacturing rules for cell and gene therapies – Morning Medical Update Medical Economics

Risky Drugs Still in the Mix for Dementia Patients - MedPage Today

Thu, 15 Jan 2026 08:00:00 GMT

Risky Drugs Still in the Mix for Dementia Patients MedPage Today

Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development - Investing News Network

Thu, 19 Feb 2026 08:00:00 GMT

Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development Investing News Network

ABL Bio lands GSK, Lilly deals to advance next-gen CNS drugs - koreabiomed.com

Thu, 13 Nov 2025 08:00:00 GMT

ABL Bio lands GSK, Lilly deals to advance next-gen CNS drugs koreabiomed.com

Mind over money: Our top CNS seed rounds you need to know about - BioXconomy

Tue, 17 Feb 2026 08:00:00 GMT

Mind over money: Our top CNS seed rounds you need to know about BioXconomy

NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs - PR Newswire

Thu, 30 Oct 2025 07:00:00 GMT

NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs PR Newswire

Lunai Bioworks acquires CNS drug delivery tech for $20M By Investing.com - Investing.com UK

Thu, 26 Mar 2026 07:00:00 GMT

Lunai Bioworks acquires CNS drug delivery tech for $20M By Investing.com Investing.com UK

Quiver Bioscience Secures Non-Dilutive Funding to Enhance CNS Genetic Medicine Drug Discovery Platform Capabilities and Advance Powerful AI/ML-Based In Vitro / In Silico Predictor of CNS Drug Safety - BioSpace

Wed, 02 Jul 2025 07:00:00 GMT

Quiver Bioscience Secures Non-Dilutive Funding to Enhance CNS Genetic Medicine Drug Discovery Platform Capabilities and Advance Powerful AI/ML-Based In Vitro / In Silico Predictor of CNS Drug Safety BioSpace

5 Depression Trials That Failed in 2025 - BioSpace

Mon, 08 Dec 2025 08:00:00 GMT

5 Depression Trials That Failed in 2025 BioSpace

ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15' - Taiwan News

Wed, 22 Apr 2026 06:13:00 GMT

ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15' Taiwan News

1910 Publishes CANDID-CNS™, an AI Model That Unlocks Beyond Rule of 5 Chemical Space and Stereochemistry to Predict Blood–Brain Barrier Penetration - Business Wire

Mon, 24 Nov 2025 08:00:00 GMT

1910 Publishes CANDID-CNS™, an AI Model That Unlocks Beyond Rule of 5 Chemical Space and Stereochemistry to Predict Blood–Brain Barrier Penetration Business Wire

This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain - AOL.com

Wed, 18 Mar 2026 07:00:00 GMT

This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain AOL.com

LG CNS Expands AI Transformation in Pharma, Healthcare Sectors - 조선일보

Thu, 05 Mar 2026 08:00:00 GMT

LG CNS Expands AI Transformation in Pharma, Healthcare Sectors 조선일보

MindBio Deploys New Technology Intox Collect™; Expands CNS Drug Detection Capabilities with Voice & Facial Recognition - The Manila Times

Mon, 13 Apr 2026 07:00:00 GMT

MindBio Deploys New Technology Intox Collect™; Expands CNS Drug Detection Capabilities with Voice & Facial Recognition The Manila Times

ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15' - The Malaysian Reserve

Wed, 22 Apr 2026 18:12:26 GMT

ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15' The Malaysian Reserve

Bexorg Raises $42.5 Million Led by Engine Ventures to Advance AI and Whole-Human Brain Platform for CNS Drug Discovery - citybiz

Wed, 15 Oct 2025 07:00:00 GMT

Bexorg Raises $42.5 Million Led by Engine Ventures to Advance AI and Whole-Human Brain Platform for CNS Drug Discovery citybiz

ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: Potential 41.67% Upside Amid Robust CNS Drug Portfolio - DirectorsTalk Interviews

Tue, 17 Feb 2026 08:00:00 GMT

ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: Potential 41.67% Upside Amid Robust CNS Drug Portfolio DirectorsTalk Interviews

Emulate Launches Brain-Chip R1 to Advance Neurological Drug Development, in Partnership with FUJIFILM Cellular Dynamics - Business Wire

Tue, 18 Nov 2025 08:00:00 GMT

Emulate Launches Brain-Chip R1 to Advance Neurological Drug Development, in Partnership with FUJIFILM Cellular Dynamics Business Wire

CNS Treatment and Therapy Market Size, Trends & Growth 2025 to 2035 - Future Market Insights

Thu, 03 Jul 2025 07:00:00 GMT

CNS Treatment and Therapy Market Size, Trends & Growth 2025 to 2035 Future Market Insights

BIO Neuroscience 2026: Connecting science, business, and innovation - amsterdamumc.org

Mon, 02 Mar 2026 08:00:00 GMT

BIO Neuroscience 2026: Connecting science, business, and innovation amsterdamumc.org

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development - Yahoo Finance

Tue, 10 Jun 2025 07:00:00 GMT

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development Yahoo Finance

Intranasal Delivery Shows Promise for Brain Targeting - Technology Networks

Wed, 04 Feb 2026 08:00:00 GMT

Intranasal Delivery Shows Promise for Brain Targeting Technology Networks

Lunai Bioworks Expands CNS Portfolio With $20M Acquisition - The Globe and Mail

Tue, 31 Mar 2026 07:00:00 GMT

Lunai Bioworks Expands CNS Portfolio With $20M Acquisition The Globe and Mail

Dallas Biotech Launches Open-Access AI Tool Targeting One of Brain Drug Discovery’s Toughest Hurdles - Dallas Innovates

Wed, 20 Aug 2025 07:00:00 GMT

Dallas Biotech Launches Open-Access AI Tool Targeting One of Brain Drug Discovery’s Toughest Hurdles Dallas Innovates

LG CNS expands AI transformation push into pharma, biotech - The Korea Times

Wed, 21 Jan 2026 08:00:00 GMT

LG CNS expands AI transformation push into pharma, biotech The Korea Times

Non-animal models for blood–brain barrier permeability evaluation of drug-like compounds - Nature

Wed, 17 Apr 2024 07:00:00 GMT

Non-animal models for blood–brain barrier permeability evaluation of drug-like compounds Nature

Cortice Biosciences Transfers Orphan Drug Designations for TPI 287 in Brain Cancer and CNS Diseases - OncLive

Wed, 21 May 2025 07:00:00 GMT

Cortice Biosciences Transfers Orphan Drug Designations for TPI 287 in Brain Cancer and CNS Diseases OncLive

Investigating blood–brain barrier penetration and neurotoxicity of natural products for central nervous system drug development - Nature

Mon, 03 Mar 2025 08:00:00 GMT

Investigating blood–brain barrier penetration and neurotoxicity of natural products for central nervous system drug development Nature

CNS Drug Delivery in Stroke: Improving Therapeutic Translation From the Bench to the Bedside - American Heart Association Journals

Fri, 22 Dec 2023 08:00:00 GMT

CNS Drug Delivery in Stroke: Improving Therapeutic Translation From the Bench to the Bedside American Heart Association Journals

CNS drug developer MapLight goes public, stock up 9% on first day of trading - The Business Journals

Mon, 27 Oct 2025 07:00:00 GMT

CNS drug developer MapLight goes public, stock up 9% on first day of trading The Business Journals

Samjin Pharmaceutical Partners with Ewha Seoul Hospital for CNS Drug Development - Seoul Economic Daily

Mon, 13 Apr 2026 07:00:00 GMT

Samjin Pharmaceutical Partners with Ewha Seoul Hospital for CNS Drug Development Seoul Economic Daily

Challenges and material innovations in drug delivery to central nervous system tumors - ScienceDirect.com

Tue, 25 Feb 2025 12:19:45 GMT

Challenges and material innovations in drug delivery to central nervous system tumors ScienceDirect.com

Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study - Nature

Thu, 29 Apr 2021 07:00:00 GMT

Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study Nature

CNS Drug Liabilities in Early Phase Clinical Trials - Applied Clinical Trials Online

Sun, 09 Aug 2020 04:38:43 GMT

CNS Drug Liabilities in Early Phase Clinical Trials Applied Clinical Trials Online

Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs - Nature

Wed, 01 Mar 2023 08:00:00 GMT

Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs Nature

How Brooklyn Health aims to modernize mental health assessment in clinical trials - Fierce Healthcare

Fri, 06 Jun 2025 07:00:00 GMT

How Brooklyn Health aims to modernize mental health assessment in clinical trials Fierce Healthcare

Assessing molecular scaffolds for CNS drug discovery - ScienceDirect.com

Fri, 15 May 2020 06:14:57 GMT

Assessing molecular scaffolds for CNS drug discovery ScienceDirect.com

Effects of Nicotine Exposure From Tobacco Products and Electronic Cigarettes on the Pathogenesis of Neurological Diseases: Impact on CNS Drug Delivery - Frontiers

Wed, 26 Jun 2024 20:12:18 GMT

Effects of Nicotine Exposure From Tobacco Products and Electronic Cigarettes on the Pathogenesis of Neurological Diseases: Impact on CNS Drug Delivery Frontiers

Delivery of drugs through the blood–brain barrier: need for trials - The Lancet

Wed, 22 Jan 2025 08:00:00 GMT

Delivery of drugs through the blood–brain barrier: need for trials The Lancet

Advance or stagnation in CNS drug development? - The Lancet

Fri, 31 Aug 2018 00:28:03 GMT

Advance or stagnation in CNS drug development? The Lancet

CNS market resurgence: a decade-long slump ends with $80bn milestone - Pharmaceutical Technology

Tue, 01 Apr 2025 07:00:00 GMT

CNS market resurgence: a decade-long slump ends with $80bn milestone Pharmaceutical Technology

Targeted to neuronal organelles for CNS drug development - ScienceDirect.com

Fri, 28 Jul 2023 07:43:16 GMT

Targeted to neuronal organelles for CNS drug development ScienceDirect.com

Drug elucidation: invertebrate genetics sheds new light on the molecular targets of CNS drugs - Frontiers

Sat, 10 Feb 2024 13:09:24 GMT

Drug elucidation: invertebrate genetics sheds new light on the molecular targets of CNS drugs Frontiers

New Haven-based bioscience firms Bexorg, Biohaven agree to collaborate - Hartford Business Journal

Wed, 11 Jun 2025 07:00:00 GMT

New Haven-based bioscience firms Bexorg, Biohaven agree to collaborate Hartford Business Journal

PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation - ScienceDirect.com

Thu, 12 Apr 2018 16:19:03 GMT

PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation ScienceDirect.com

Sanofi taps Alloy Therapeutics for CNS antisense drug development - Pharmaceutical Technology

Wed, 08 Jan 2025 08:00:00 GMT

Sanofi taps Alloy Therapeutics for CNS antisense drug development Pharmaceutical Technology

Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma - Nature

Tue, 07 Jan 2025 08:00:00 GMT

Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma Nature

Drug development for CNS disorders: strategies for balancing risk and reducing attrition - Nature

Sun, 25 Feb 2018 00:40:29 GMT

Drug development for CNS disorders: strategies for balancing risk and reducing attrition Nature

CNS therapeutics: Immune cells break the barriers - Science | AAAS

Wed, 08 Nov 2023 08:00:00 GMT

CNS therapeutics: Immune cells break the barriers Science | AAAS

Modifying a Chemotherapy Drug Offers Hope to People with Rare Brain and Spine Tumors - National Cancer Institute (.gov)

Tue, 09 Jul 2024 07:00:00 GMT

Modifying a Chemotherapy Drug Offers Hope to People with Rare Brain and Spine Tumors National Cancer Institute (.gov)

Overcoming Blood-Brain Barrier Resistance: Implications for Extracellular Vesicle-Mediated Drug Brain Delivery - Frontiers

Fri, 28 Jun 2024 00:31:53 GMT

Overcoming Blood-Brain Barrier Resistance: Implications for Extracellular Vesicle-Mediated Drug Brain Delivery Frontiers

Industrializing behavioral testing to redefine neuropsychiatric drug discovery - Nature

Mon, 18 Jul 2022 13:43:30 GMT

Industrializing behavioral testing to redefine neuropsychiatric drug discovery Nature

Locoregional CAR T Cells for the Treatment of CNS Tumors in Children: Investigational Drug Service Pharmacy Activities - Journal of Hematology Oncology Pharmacy

Tue, 14 Jan 2025 20:59:55 GMT

Locoregional CAR T Cells for the Treatment of CNS Tumors in Children: Investigational Drug Service Pharmacy Activities Journal of Hematology Oncology Pharmacy

The CNS drug development drum beat is getting louder - drugdiscoverytrends.com

Mon, 01 Aug 2022 07:00:00 GMT

The CNS drug development drum beat is getting louder drugdiscoverytrends.com

Frontrunners in CNS Drug Delivery - PharmTech.com

Tue, 07 May 2024 07:00:00 GMT

Frontrunners in CNS Drug Delivery PharmTech.com

Use of functional imaging across clinical phases in CNS drug development | Translational Psychiatry - Nature

Tue, 16 Jul 2013 07:00:00 GMT

Use of functional imaging across clinical phases in CNS drug development | Translational Psychiatry Nature

Lario Therapeutics secures $2.4m in grants from Michael J. Fox Foundation and Wellcome to expand CNS drug platform - Insider Media Ltd

Fri, 20 Feb 2026 08:00:00 GMT

Lario Therapeutics secures $2.4m in grants from Michael J. Fox Foundation and Wellcome to expand CNS drug platform Insider Media Ltd